Form 4: UMH Properties Director Amy Lynn Butewicz Reports Changes in Beneficial Ownership

Sentiment:

SEC Form 4 Filing


Director Amy Lynn Butewicz reports changes in beneficial ownership of UMH Properties, Inc. stock, including acquisitions through dividend reinvestment.

Summary

  • On June 17, 2024, Amy Lynn Butewicz, a director of UMH Properties, Inc., reported changes in her beneficial ownership of the company's stock.
  • The report includes the acquisition of 153 shares through dividend reinvestment.
  • Butewicz directly owns 11,632.69 shares of UMH Properties, Inc. common stock following the reported transaction.
  • She also holds derivative securities, including options to purchase 11,000 shares exercisable between January 10, 2025, and January 10, 2034, with an exercise price of $15.80.
  • Additionally, she holds options to purchase 10,000 shares exercisable between March 21, 2024, and March 21, 2033, with an exercise price of $14.36.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing showing a director's transactions, with a slight positive leaning due to the dividend reinvestment indicating confidence.

Positives

  • The director's continued ownership and acquisition of shares through dividend reinvestment could be seen as a positive sign of confidence in the company.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the director's ongoing investment in the company.

Stakeholder Impact

  • The filing provides transparency to shareholders regarding insider transactions.

Key Dates

DateDescription
03/21/2024Options for 10,000 shares exercisable between March 21, 2024, and March 21, 2033, with an exercise price of $14.36.
06/17/2024Date of the reported transaction, including dividend reinvestment.
07/02/2024Date of signature on the Form 4 filing.
01/10/2025Options for 11,000 shares exercisable between January 10, 2025, and January 10, 2034, with an exercise price of $15.80.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.